News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,515 Results
Type
Article (61302)
Company Profile (69)
Press Release (584144)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (173934)
Career Advice (2730)
Deals (32436)
Drug Delivery (97)
Drug Development (76973)
Employer Resources (150)
FDA (14936)
Job Trends (13893)
News (305249)
Policy (28966)
Tag
Academia (2894)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (88)
Alliances (43237)
ALS (88)
Alzheimer's disease (1322)
Antibody-drug conjugate (ADC) (110)
Approvals (14952)
Artificial intelligence (264)
Autoimmune disease (23)
Automation (15)
Bankruptcy (292)
Best Places to Work (10858)
BIOSECURE Act (16)
Biosimilars (102)
Biotechnology (51)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (273)
Cancer (2184)
Cardiovascular disease (165)
Career advice (2313)
Career pathing (33)
CAR-T (154)
Cell therapy (429)
Cervical cancer (20)
Clinical research (62578)
Collaboration (786)
Company closure (1)
Compensation (334)
Complete response letters (20)
COVID-19 (2572)
CRISPR (43)
C-suite (260)
Cystic fibrosis (100)
Data (2153)
Decentralized trials (2)
Denatured (25)
Depression (43)
Diabetes (253)
Diagnostics (6154)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (114)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60238)
Editorial (39)
Employer branding (18)
Employer resources (132)
Events (94515)
Executive appointments (760)
FDA (16191)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (747)
Gene editing (110)
Generative AI (20)
Gene therapy (299)
GLP-1 (667)
Government (4464)
Grass and pollen (6)
Guidances (64)
Healthcare (18210)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (28)
Infectious disease (2705)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (527)
IPO (14789)
IRA (38)
Job creations (3420)
Job search strategy (1942)
Kidney cancer (10)
Labor market (30)
Layoffs (503)
Leadership (22)
Legal (6441)
Liver cancer (69)
Lung cancer (304)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (279)
MASH (63)
Medical device (12658)
Medtech (12663)
Mergers & acquisitions (18223)
Metabolic disorders (635)
Multiple sclerosis (77)
NASH (13)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1839)
NextGen: Class of 2025 (6374)
Non-profit (4320)
Now hiring (12)
Obesity (321)
Opinion (232)
Ovarian cancer (71)
Pain (91)
Pancreatic cancer (79)
Parkinson's disease (141)
Partnered (21)
Patents (234)
Patient recruitment (112)
Peanut (50)
People (59588)
Pharmaceutical (20)
Pharmacy benefit managers (15)
Phase I (19715)
Phase II (27599)
Phase III (20156)
Pipeline (1144)
Policy (125)
Postmarket research (2474)
Preclinical (8423)
Press Release (67)
Prostate cancer (107)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (360)
Real estate (5991)
Recruiting (61)
Regulatory (20114)
Reports (33)
Research institute (2400)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (68)
Series A (131)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3346)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (26)
The Weekly (32)
Vaccines (665)
Venture capitalists (34)
Weight loss (204)
Women's health (30)
Worklife (19)
Date
Today (17)
Last 7 days (756)
Last 30 days (2319)
Last 365 days (30375)
2025 (10176)
2024 (32295)
2023 (36353)
2022 (46629)
2021 (51583)
2020 (50746)
2019 (44794)
2018 (34070)
2017 (30723)
2016 (30075)
2015 (35457)
2014 (28387)
2013 (24985)
2012 (26251)
2011 (26476)
2010 (24973)
Location
Africa (872)
Alabama (54)
Alaska (6)
Arizona (171)
Arkansas (14)
Asia (38061)
Australia (6852)
California (5562)
Canada (1869)
China (489)
Colorado (248)
Connecticut (259)
Delaware (140)
Europe (88567)
Florida (848)
Georgia (199)
Idaho (56)
Illinois (548)
India (25)
Indiana (280)
Iowa (10)
Japan (153)
Kansas (95)
Kentucky (24)
Louisiana (10)
Maine (61)
Maryland (828)
Massachusetts (4021)
Michigan (222)
Minnesota (339)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (57)
New Hampshire (61)
New Jersey (1641)
New Mexico (29)
New York (1630)
North Carolina (965)
North Dakota (9)
Northern California (2410)
Ohio (195)
Oklahoma (15)
Oregon (36)
Pennsylvania (1235)
Puerto Rico (12)
Rhode Island (31)
South America (1178)
South Carolina (17)
South Dakota (1)
Southern California (2130)
Tennessee (95)
Texas (849)
United States (21269)
Utah (173)
Virginia (143)
Washington D.C. (50)
Washington State (512)
West Virginia (3)
Wisconsin (60)
645,515 Results for "university of montreal".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ability Biotherapeutics Moves to Inspire Bio Innovations in Montreal, Pioneering the New Generation of Targeted Antibodies
April 29, 2025
·
4 min read
Press Releases
Shining a spotlight on the Montreal Chest Institute
February 28, 2025
·
5 min read
Press Releases
INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society
--Data will be presented at the conference in October in Montreal
September 25, 2024
·
3 min read
Montreal team is developing a breakthrough brain implant to boost mobility after spinal cord injuries
A presidential scholar from Pennsylvania is in Montreal this summer, applying her expertise to help a state-of-the-art lab at École Polytechnique de Montréal advance a breakthrough medical device that enables people with spinal cord injuries to move their limbs.
July 24, 2023
·
4 min read
Pharm Country
University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery
Helius Medical Technologies, Inc. announced it has signed an agreement with the School of Rehabilitation at the Université de Montréal for the purchase of ten PoNS devices to be used in a research project linked to stroke recovery.
September 20, 2023
·
6 min read
FDA
The Montreal Heart Institute Welcomes FDA Approval of Colchicine for the Treatment of Cardiovascular Diseases
The Montreal Heart Institute (MHI) welcomes the approval by the United States Food and Drug Administration (FDA) of colchicine for cardiovascular prevention.
June 23, 2023
·
2 min read
Business
Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
Novocure announced it has opened a new office in Montreal to expand and support its growing business in Canada.
November 15, 2022
·
6 min read
CDMO C3i Center Inc Located in Montreal, Canada Has Begun Manufacturing a Cell Therapy Product for Europe
The Montreal-based CDMO C3i Center Inc is paving the way in the cell and gene therapy industry in North American and Canada as one of a few contract development and manufacturing organizations (CDMOs) to be producing in North America and for Europe.
September 20, 2023
·
1 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
Alpha Tau Medical Ltd. announced today that its first patient with liver cancer metastases has been treated in a feasibility and safety study of Alpha DaRT at the McGill University Health Center in Montreal, Canada.
May 13, 2024
·
6 min read
1 of 64,552
Next
